Stocks and Investing
Stocks and Investing
Thu, February 24, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, February 23, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (TDOC) at Buy with Decreased Target to $130 on, Feb 23rd, 2022
Michael Wiederhorn of Oppenheimer, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $160 to $130 on, Feb 23rd, 2022.
Michael has made no other calls on TDOC in the last 4 months.
There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 4 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $81 on, Tuesday, January 25th, 2022
- David Larsen of "BTIG" Downgraded from Strong Buy to Hold on, Monday, November 22nd, 2021
- Scott Schoenhaus of "Stephens & Co." Maintained at Hold with Decreased Target to $135 on, Friday, November 19th, 2021
These are the ratings of the 7 analyists that currently disagree with Michael
- Cindy Motz of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Friday, February 11th, 2022
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, November 23rd, 2021
- Daniel Grosslight of "Citigroup" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 19th, 2021
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $207 on, Friday, November 19th, 2021
- Stephanie Davis of "SVB Leerink" Maintained at Buy with Decreased Target to $193 on, Friday, November 19th, 2021
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $215 on, Monday, November 15th, 2021
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $165 on, Friday, October 29th, 2021
Contributing Sources